跳至主要内容
临床试验/ACTRN12622001165774
ACTRN12622001165774招募中未知

Survivorship Care For Long-Term Responder Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC): Feasibility of a Multi-Disciplinary Team (MDT) Consultation

Chris O'Brien Lifehouse0 个研究点目标入组 30 人开始时间: 2022年8月24日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Histologically confirmed unresectable locally advanced or metastatic NSCLC
  • 2. Age >/= 18 years
  • 3. Able to understand, speak and read in English without the use of an interpreter
  • 4. >/= 6 months post initiation of current line of systemic therapy without radiological evidence of disease progression (stable disease, complete or partial response on CT performed within 3 months prior to enrolment; or complete or partial metabolic response, or stable disease on PET)
  • 5. Able to give informed written consent
  • 6. Access to computer with internet connection

排除标准

  • 1. Psychiatric comorbidity that would preclude participation in the study procedures
  • 2. A diagnosis of unresectable NSCLC that is being managed with ‘definitive’ or ‘curative’ intent (eg patients with stage III NSCLC undergoing concurrent chemoradiotherapy followed by consolidation durvalumab)

研究者

相似试验

Survivorship Care For Long-Term Responder Patients... | 临床试验